Catalyst Crew Technologies Corp. (OTC: CCTC) announced the establishment of LataMed AI VE, C.A., a Venezuelan operating subsidiary designed to support the company's telehealth regulatory, commercialization, and healthcare deployment initiatives in Venezuela. The subsidiary is expected to commence operations in the coming weeks, pending regulatory progression and operational readiness.
LataMed AI VE, C.A. will serve as a localized entity to manage telehealth platform deployment, patient onboarding, provider coordination, and healthcare analytics integration. It will work alongside the company's existing framework, including Inversiones Long 33, C.A., as part of a broader regional infrastructure strategy aimed at strengthening regulatory flexibility and commercialization scalability in Latin America.
Management believes that this subsidiary will enhance the company's ability to efficiently manage localized healthcare operations, support phased commercialization, and facilitate broader telehealth platform expansion across Venezuela and other targeted Latin American markets. The company continues to advance its telehealth platform development and testing through its interface at https://latamedai.org.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: "The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution."
The company is coordinating regulatory initiatives with healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader healthcare infrastructure and commercialization objectives. For more information, visit https://catalystcrewai.com or review the company's SEC filings at www.sec.gov.
This announcement underscores Catalyst Crew's commitment to expanding its AI-driven healthcare technology platform in emerging markets, with an initial focus on Latin America. The establishment of LataMed AI VE, C.A. is a critical step in building an integrated healthcare technology platform to address the growing demand for modernized healthcare delivery systems in the region.
